Atlas Trials

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

Clinical trial NCT00000392 · COMPLETED

Trial details

NCT number
NCT00000392
Sponsor
National Institute of Mental Health (NIMH)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV InfectionsCognition Disorders
Start date
1990-01-01
Primary completion
1996-08-01
Enrollment
215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.